CRISPR: Move Beyond Differences
By Charis Thompson,
Nature
| 06. 24. 2015
Untitled Document
This autumn, researchers and other experts will come together to discuss the scientific, ethical and policy issues associated with gene-editing research in humans. Plans for the international meeting were announced by the US National Academy of Sciences and the National Academy of Medicine after a study was published in which researchers used a gene-editing tool known as CRISPR to modify the genomes of non-viable human embryos1.
Whether this meeting and others like it, planned in the United States, can help to forge a path for gene editing that takes into account all the relevant needs and concerns will depend on what efforts are made to integrate the diverse perspectives of people with different expertise and values. A first step to such integration is understanding how different perspectives arise.
One division in cares and concerns seems at times to fall along stereotypical gender lines. This was powerfully demonstrated during a meeting in Atlanta, Georgia, last month on biotechnology and ethics. About 200 global thought leaders gathered at BEINGS 2015 to “reach consensus on the direction of biotechnology...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
